Place · Level 3 · Foundation
Weight Management · Foundations
减肥不是意志力问题 · BMI 是工具不是分数 · 能量平衡是动态系统 · 身体会反弹防御 · 入口枢纽链接 9 个深度 story
Story path
Chapter 1
Why weight matters
Why weight matters
Body weight is a metabolic question, not an aesthetic one. Fat distribution shifts insulin sensitivity, cardiovascular event rates, joint load, sleep-disordered breathing, and hormonal axes — none of which depend on what the mirror shows, but on the ratio of visceral fat to muscle.
BMI is an epidemiological tool, not a personal health score. The Global BMI Mortality Collaboration (Lancet 2016) pooled 239 prospective cohorts, n=10.6 million, excluding prior chronic disease and smokers. Across ages 35-89 it found a classic J-shaped curve for all-cause mortality, with the nadir between BMI 20.0-25.0 kg/m². Hazard ratios climbed +7% at 25-27.5, +20% at 27.5-30, +45% at 30-35, +94% at 35-40, and +176% at 40-45. The low end (< 18.5) also carried excess risk, mostly from frailty and occult illness.
Limits worth remembering:
BMI cannot distinguish muscle from fat — a bodybuilder at BMI 27 carries no equivalent metabolic riskIt cannot localize where fat sits — visceral adipose is far more pathogenic than subcutaneousEthnic differences: East and South Asians develop type-2 diabetes and CV risk at lower BMI; WHO's working thresholds for Asian populations are 23 (overweight) and 27.5 (obese)Older adults (> 65): mortality is lowest at BMI 23-27; being too thin is harmful (sarcopenia)
At the individual level, layer three complementary measures on top of BMI:
Waist circumference: men ≥ 90 cm / women ≥ 85 cm (Asian criteria) flags central adiposityWaist-hip ratio (WHR): men > 0.9 / women > 0.85 suggests elevated visceral fatBody-fat percentage (DEXA most accurate, BIA only indicative): men > 25% / women > 32% indicates metabolic risk
The number on the scale is harmless; the metabolic substrate it reflects is not. That is why Atlas locates weight management inside the conditions region, not under cosmetics.
BMI is an epidemiological tool, not a personal health score. The Global BMI Mortality Collaboration (Lancet 2016) pooled 239 prospective cohorts, n=10.6 million, excluding prior chronic disease and smokers. Across ages 35-89 it found a classic J-shaped curve for all-cause mortality, with the nadir between BMI 20.0-25.0 kg/m². Hazard ratios climbed +7% at 25-27.5, +20% at 27.5-30, +45% at 30-35, +94% at 35-40, and +176% at 40-45. The low end (< 18.5) also carried excess risk, mostly from frailty and occult illness.
Limits worth remembering:
BMI cannot distinguish muscle from fat — a bodybuilder at BMI 27 carries no equivalent metabolic riskIt cannot localize where fat sits — visceral adipose is far more pathogenic than subcutaneousEthnic differences: East and South Asians develop type-2 diabetes and CV risk at lower BMI; WHO's working thresholds for Asian populations are 23 (overweight) and 27.5 (obese)Older adults (> 65): mortality is lowest at BMI 23-27; being too thin is harmful (sarcopenia)
At the individual level, layer three complementary measures on top of BMI:
Waist circumference: men ≥ 90 cm / women ≥ 85 cm (Asian criteria) flags central adiposityWaist-hip ratio (WHR): men > 0.9 / women > 0.85 suggests elevated visceral fatBody-fat percentage (DEXA most accurate, BIA only indicative): men > 25% / women > 32% indicates metabolic risk
The number on the scale is harmless; the metabolic substrate it reflects is not. That is why Atlas locates weight management inside the conditions region, not under cosmetics.
Myth · normal BMI = healthy?
'My BMI is normal, so my metabolism is fine' is one of the most common misreadings in the weight conversation — it treats a population statistic as a personal lab report.Two kinds of people that BMI easily misses:
TOFI (thin outside, fat inside): scale and BMI both normal, but visceral fat is high and muscle is low. Their risk of insulin resistance, fatty liver, and dyslipidemia is genuinely not low, yet they often go completely unscreened because they 'aren't fat'. East and South Asians fall into this category especially often — which is exactly why WHO lowered the Asian thresholds (23 / 27.5).The metabolically healthy higher-BMI person: some people with elevated BMI carry plenty of muscle, store fat mostly subcutaneously, and have normal metabolic markers; their short-term risk isn't as high as the number suggests. Whether they stay 'healthy' over time remains debated, but at minimum it shows BMI alone can't decide who is ill.
The more reliable approach is to treat BMI as a coarse first filter, then complete the picture with waist circumference, waist-hip ratio, body-fat percentage, fasting glucose / HbA1c, lipids, and blood pressure. A person at BMI 24 with an over-threshold waist and elevated fasting glucose deserves more attention than someone at BMI 27 with a slim waist and all markers green.
This isn't to dismiss BMI — it's a reminder: it answers 'what is the average risk in this population', not 'how is your particular body doing right now'. Don't conflate the two questions.
Chapter 2
Energy balance is dynamic
Energy balance is dynamic
CICO (Calories In, Calories Out) is physically correct — the first law of thermodynamics is non-negotiable. But its popular simplification — 'eat 500 kcal less per day and lose ~0.45 kg per week because 1 kg of fat = 7700 kcal' — comes from a 1958 algebraic shortcut and almost never holds in real humans.
Why 7700 kcal/kg is a simplification:
Hall 2011 Lancet modelled metabolic-ward isocaloric data and showed weight decays asymptotically, not linearlyAfter ~6 months, actual loss is typically 50-70% of what the static formula predicts, because the body itself changes
Total energy expenditure (TEE) has four components:
RMR (resting metabolic rate): ~60-70%, set by lean mass (muscle, liver, kidney, brain)TEF (thermic effect of food): ~10%; protein ~25%, carbs ~8%, fat ~3%EAT (planned exercise): ~5-15%NEAT (non-exercise activity thermogenesis): ~15-30%, the easiest component for the body to quietly downregulate — walking a bit slower, fidgeting less, smaller gestures can swing 200-500 kcal/day without conscious awareness
Hall 2015 Cell Metabolism, metabolic-ward RCT:
In a strict ward, obese participants underwent matched 30% caloric reductions either from carbs or from fat for 6 days. The static formula predicts identical fat loss; measured fat oxidation was ~80% greater in the fat-reduction arm. It's a short study, but the implication is real: at identical calories, macronutrient structure changes how energy is partitioned. The point isn't 'carbs make you fat' — it's that 'same calories, different bodily response' is a physically measurable phenomenon, not folklore.
The dynamic nature of energy balance:
You lose weight → RMR drops (less lean mass + adaptive thermogenesis)You eat less → NEAT quietly fallsYou move more → appetite rises slightly, and activity in other parts of the day declines (Pontzer 2016 'constrained TEE' hypothesis)Net result: the larger and longer the deficit, the stronger the body's defensive response
There is also the measurement problem itself: most people cannot accurately know how much they take in or burn each day. Lichtman 1992 NEJM used doubly-labelled water for objective measurement in obese subjects and found they under-reported intake by ~47% and over-reported activity by ~51% — not deliberate lying, but inherently poor human self-estimates of food and activity. So a plate that feels tiny is often an estimation error, not a broken metabolism.
CICO is a framework, not a prescription. What actually works is a moderate deficit + lean-mass preservation + long-term sustainability — not '-1000 kcal/day and watch the scale crash'.
Why 7700 kcal/kg is a simplification:
Hall 2011 Lancet modelled metabolic-ward isocaloric data and showed weight decays asymptotically, not linearlyAfter ~6 months, actual loss is typically 50-70% of what the static formula predicts, because the body itself changes
Total energy expenditure (TEE) has four components:
RMR (resting metabolic rate): ~60-70%, set by lean mass (muscle, liver, kidney, brain)TEF (thermic effect of food): ~10%; protein ~25%, carbs ~8%, fat ~3%EAT (planned exercise): ~5-15%NEAT (non-exercise activity thermogenesis): ~15-30%, the easiest component for the body to quietly downregulate — walking a bit slower, fidgeting less, smaller gestures can swing 200-500 kcal/day without conscious awareness
Hall 2015 Cell Metabolism, metabolic-ward RCT:
In a strict ward, obese participants underwent matched 30% caloric reductions either from carbs or from fat for 6 days. The static formula predicts identical fat loss; measured fat oxidation was ~80% greater in the fat-reduction arm. It's a short study, but the implication is real: at identical calories, macronutrient structure changes how energy is partitioned. The point isn't 'carbs make you fat' — it's that 'same calories, different bodily response' is a physically measurable phenomenon, not folklore.
The dynamic nature of energy balance:
You lose weight → RMR drops (less lean mass + adaptive thermogenesis)You eat less → NEAT quietly fallsYou move more → appetite rises slightly, and activity in other parts of the day declines (Pontzer 2016 'constrained TEE' hypothesis)Net result: the larger and longer the deficit, the stronger the body's defensive response
There is also the measurement problem itself: most people cannot accurately know how much they take in or burn each day. Lichtman 1992 NEJM used doubly-labelled water for objective measurement in obese subjects and found they under-reported intake by ~47% and over-reported activity by ~51% — not deliberate lying, but inherently poor human self-estimates of food and activity. So a plate that feels tiny is often an estimation error, not a broken metabolism.
CICO is a framework, not a prescription. What actually works is a moderate deficit + lean-mass preservation + long-term sustainability — not '-1000 kcal/day and watch the scale crash'.
Practical · 4 levers, not arithmetic
Once you accept that energy balance is a dynamic system, the practical side actually gets easier: you don't have to count kcal precisely each day, because that number was never accurately estimable anyway. Rather than fighting the arithmetic, manage the few levers that genuinely move the outcome.Protein first: treat 25-40 g per meal as a floor. Protein's thermic effect (TEF) is ~25%, higher than carbs or fat, and it is the most satiating macronutrient — so it quietly lowers net intake without you deliberately eating less.Put NEAT on a visible track: the prior page showed the body quietly dials down walking, fidgeting, and standing — non-exercise activity you can't feel but the scale can. Give yourself a fixed step target (say 7,000-10,000/day) to move this from 'by feel' to 'measured'.Slow, not savage: a moderate deficit (0.5-1% of body weight per week, roughly -300 to -500 kcal/day) triggers far gentler bodily defense than slashing 1,000 kcal a day. The faster you push, the stronger the rebound.Watch the trend, not the single day: weight can swing 1-2 kg in a day from water, salt, and glycogen. Use a 7-day moving average to read direction; the daily number is mostly noise.
In one line: since 'how much in, how much out' is inherently unmeasurable, spending energy on biasing your defaults toward your goal pays off far more than counting decimals in a spreadsheet.
Chapter 3
Why it's hard
Why it's hard
Losing weight isn't the hard part — keeping it off is. Epidemiology is consistent: almost any method can produce 5-10% loss at 6-12 months, but 70-80% of people return to or above baseline within 3-5 years. The issue isn't 'wrong method' or 'weak willpower' — the body actively defends.
Sumithran 2011 NEJM:
50 overweight/obese adults completed a 10-week very-low-calorie diet (losing ~13.5 kg) and were followed for one full year. Despite some weight regain, hormonal signals remained in 'starvation mode' at 12 months: leptin ↓ (weaker satiety), ghrelin ↑ (stronger hunger), glucagon-like peptide-1: A gut hormone released after eating that makes you feel full and helps lower blood sugar. / PYY / CCK all shifted toward 'eat more', and subjective hunger scores were significantly above baseline. The headline finding: these hormonal changes persist a full year after the loss, not just weeks.
Fothergill 2016 Obesity (Biggest Loser 6-year follow-up):
14 contestants lost an average of 58 kg during a 30-week show. Six years later, 13 had regained substantial weight (still averaging ~12 kg below baseline), yet resting metabolic rate remained ~500 kcal/day below baseline — far more than the loss of lean mass alone can explain. This 'RMR doesn't return even after regain' phenomenon is adaptive thermogenesis, reviewed in Rosenbaum 2010 Int J Obes: after 10% weight loss, total energy expenditure falls roughly 10-15% beyond what lean-mass change predicts, and the deficit persists for years.
Mechanisms:
Leptin drops → hypothalamic 'energy-shortage' alarm → drive to eat rises + energy expenditure fallsThyroid T3 falls → basal temperature/metabolism turned downSympathetic activity drops → NEAT spontaneously decreasesSkeletal-muscle efficiency rises → same movement burns fewer caloriesReward system: food's dopamine response intensifies — energy-dense foods look extra rewarding
None of this is 'willpower failure' — it's a survival circuit honed over hundreds of thousands of years, continuously triggered in a modern food-abundant environment.
Practical implications:
Stop self-blaming 'why can't I control myself' — you are fighting an evolutionarily robust designAny weight-loss plan must assume the maintenance phase needs more tools than the loss phaseRegain isn't failure — it's the system running as designed; the real target is keeping regain to < 50% of the original lossSlower loss (0.5-1%/week) triggers somewhat weaker defense than rapid loss (> 1.5%/week) — indirect evidence, but clinical guidelines lean slow
This isn't an excuse to quit — it's a map of the battlefield. Once you see it clearly, you know which tools matter.
Sumithran 2011 NEJM:
50 overweight/obese adults completed a 10-week very-low-calorie diet (losing ~13.5 kg) and were followed for one full year. Despite some weight regain, hormonal signals remained in 'starvation mode' at 12 months: leptin ↓ (weaker satiety), ghrelin ↑ (stronger hunger), glucagon-like peptide-1: A gut hormone released after eating that makes you feel full and helps lower blood sugar. / PYY / CCK all shifted toward 'eat more', and subjective hunger scores were significantly above baseline. The headline finding: these hormonal changes persist a full year after the loss, not just weeks.
Fothergill 2016 Obesity (Biggest Loser 6-year follow-up):
14 contestants lost an average of 58 kg during a 30-week show. Six years later, 13 had regained substantial weight (still averaging ~12 kg below baseline), yet resting metabolic rate remained ~500 kcal/day below baseline — far more than the loss of lean mass alone can explain. This 'RMR doesn't return even after regain' phenomenon is adaptive thermogenesis, reviewed in Rosenbaum 2010 Int J Obes: after 10% weight loss, total energy expenditure falls roughly 10-15% beyond what lean-mass change predicts, and the deficit persists for years.
Mechanisms:
Leptin drops → hypothalamic 'energy-shortage' alarm → drive to eat rises + energy expenditure fallsThyroid T3 falls → basal temperature/metabolism turned downSympathetic activity drops → NEAT spontaneously decreasesSkeletal-muscle efficiency rises → same movement burns fewer caloriesReward system: food's dopamine response intensifies — energy-dense foods look extra rewarding
None of this is 'willpower failure' — it's a survival circuit honed over hundreds of thousands of years, continuously triggered in a modern food-abundant environment.
Practical implications:
Stop self-blaming 'why can't I control myself' — you are fighting an evolutionarily robust designAny weight-loss plan must assume the maintenance phase needs more tools than the loss phaseRegain isn't failure — it's the system running as designed; the real target is keeping regain to < 50% of the original lossSlower loss (0.5-1%/week) triggers somewhat weaker defense than rapid loss (> 1.5%/week) — indirect evidence, but clinical guidelines lean slow
This isn't an excuse to quit — it's a map of the battlefield. Once you see it clearly, you know which tools matter.
Clinical · maintenance is the main fight
The scenes above explained why the body defends. This page translates that into one clinical mindset worth keeping: the real exam in a weight plan is the maintenance phase, not the loss phase.Most people stake all their energy on the first 12 weeks — when it's novel, the number is dropping, and motivation peaks. But the hormonal counterattack (chronically elevated ghrelin, lowered leptin, suppressed resting metabolism) fully unfolds precisely after you've 'finished', and per Sumithran 2011 it persists at least a year, per Fothergill 2016 possibly for years. In other words, you must resist the body's strongest pull at the moment your motivation is weakest.
So a realistic plan looks like this:
Set the goal as 'still there in 3 years', not 'how much in 3 months'. Clinically, a sustained 5-10% loss already clearly improves glucose, blood pressure, and joint load.Prepare maintenance tools in advance: a fixed protein breakfast, a fixed step count, fixed strength-training days, a predictable meal rhythm — the people who keep weight off long term share exactly these boring routines, not some aggressive method.Redefine rebound: regain is not moral failure, it's the system running as designed. Aiming to 'keep regain under half the original loss' is far more realistic than 'never regain', and far less likely to make you quit entirely over one small bounce.Accept a lower maintenance intake: post-loss, holding the same weight may require eating a couple hundred calories less per day than a same-weight person who was never heavier. That's a setting, not a mistake you made.
See this clearly and you won't write yourself off as a failure at week 16 when 'it stopped moving' — you've just walked into the real exam room.
Chapter 4
What actually works
What actually works
No single diet wins. DIETFITS (Gardner 2018 JAMA) randomized 609 adults to low-fat or low-carb for 12 months: -5.3 vs -6.0 kg, not significantly different. What repeatedly wins across trials is adherence + protein + resistance training + sleep + realistic expectations — not a magical macronutrient ratio.
Evidence-grade gold standard for long-term loss:
Moderate caloric deficit: 0.5-1% of body weight per week = roughly -300 to -500 kcal/day. Larger deficits trigger stronger hormonal defense (see prior scene)Protein ≥ 1.6 g/kg/day (target or lean mass basis): multiple meta-analyses show preservation of lean mass under deficit + improved satiety. Diminishing returns above ~2.4 g/kgResistance training ≥ 2-3 sessions/week: without RT, 25-30% of weight lost is muscle; with RT this drops to < 10%Sleep 7-9 h/day: with sleep restricted to 5 h, even at matched calories, the share of weight lost as fat drops sharply and lean-mass loss rises (Nedeltcheva 2010)Realistic expectations: 5-10% loss at 1 year is clinically meaningful (improves glucose, BP, joint pain); 20-30% typically requires medication or surgery
Look AHEAD (NEJM 2013) evaluated intensive lifestyle intervention (ILI) in 5145 adults with type-2 diabetes, with 9.6 years of follow-up: ILI -8.6% vs control -0.7% at year 1. Long-term, ILI did not significantly reduce cardiovascular events (the control arm benefited from study attention), but the subgroup with ≥ 10% loss showed clear CV benefit, and ILI improved BP, HbA1c, HDL, walking capacity, and depression scores. By year 8, ILI's net retained loss had drifted to -4.7%, confirming regain is universal.
When to consider pharmacotherapy (glucagon-like peptide-1: A gut hormone released after eating that makes you feel full and helps lower blood sugar. class etc.):
Clinical thresholds (most FDA 2024 labels): BMI ≥ 30, or BMI ≥ 27 + at least one weight-related comorbidity (hypertension / dyslipidemia / type-2 diabetes / OSA)STEP 1 (Wilding 2021 NEJM): semaglutide 2.4 mg/wk for 68 weeks produced -14.9% (vs -2.4% control). One year after discontinuation, ~2/3 of the loss was regained (Wilding 2022 extension) — chronic disease, chronic treatmentSee atlas `glp1-agonists-deep`
When to consider bariatric surgery:
ASMBS/IFSO 2022 guidelines (Eisenberg 2022): BMI ≥ 35 (with or without comorbidity), or BMI ≥ 30 + metabolic disease (T2DM); Asian thresholds shift down by ~2.5Sustained -25 to -30% loss, high T2DM remission rate, but requires lifelong follow-up and micronutrient supplementationSee atlas `bariatric-surgery-truth`
Shared features of effective interventions:
Sustainability beats intensityProtein and resistance training protect the metabolic chassisSleep and stress management are hidden leversDrugs and surgery are real options, not signs of failureAligned expectations are the strongest tool against dropout
Evidence-grade gold standard for long-term loss:
Moderate caloric deficit: 0.5-1% of body weight per week = roughly -300 to -500 kcal/day. Larger deficits trigger stronger hormonal defense (see prior scene)Protein ≥ 1.6 g/kg/day (target or lean mass basis): multiple meta-analyses show preservation of lean mass under deficit + improved satiety. Diminishing returns above ~2.4 g/kgResistance training ≥ 2-3 sessions/week: without RT, 25-30% of weight lost is muscle; with RT this drops to < 10%Sleep 7-9 h/day: with sleep restricted to 5 h, even at matched calories, the share of weight lost as fat drops sharply and lean-mass loss rises (Nedeltcheva 2010)Realistic expectations: 5-10% loss at 1 year is clinically meaningful (improves glucose, BP, joint pain); 20-30% typically requires medication or surgery
Look AHEAD (NEJM 2013) evaluated intensive lifestyle intervention (ILI) in 5145 adults with type-2 diabetes, with 9.6 years of follow-up: ILI -8.6% vs control -0.7% at year 1. Long-term, ILI did not significantly reduce cardiovascular events (the control arm benefited from study attention), but the subgroup with ≥ 10% loss showed clear CV benefit, and ILI improved BP, HbA1c, HDL, walking capacity, and depression scores. By year 8, ILI's net retained loss had drifted to -4.7%, confirming regain is universal.
When to consider pharmacotherapy (glucagon-like peptide-1: A gut hormone released after eating that makes you feel full and helps lower blood sugar. class etc.):
Clinical thresholds (most FDA 2024 labels): BMI ≥ 30, or BMI ≥ 27 + at least one weight-related comorbidity (hypertension / dyslipidemia / type-2 diabetes / OSA)STEP 1 (Wilding 2021 NEJM): semaglutide 2.4 mg/wk for 68 weeks produced -14.9% (vs -2.4% control). One year after discontinuation, ~2/3 of the loss was regained (Wilding 2022 extension) — chronic disease, chronic treatmentSee atlas `glp1-agonists-deep`
When to consider bariatric surgery:
ASMBS/IFSO 2022 guidelines (Eisenberg 2022): BMI ≥ 35 (with or without comorbidity), or BMI ≥ 30 + metabolic disease (T2DM); Asian thresholds shift down by ~2.5Sustained -25 to -30% loss, high T2DM remission rate, but requires lifelong follow-up and micronutrient supplementationSee atlas `bariatric-surgery-truth`
Shared features of effective interventions:
Sustainability beats intensityProtein and resistance training protect the metabolic chassisSleep and stress management are hidden leversDrugs and surgery are real options, not signs of failureAligned expectations are the strongest tool against dropout
Clinical · when drugs, when surgery
'Should I be on a weight-loss drug / consider surgery' is a question to answer with thresholds, not shame. Laying out the decision path is more useful than agonizing over whether it 'counts as cheating'.The ladder runs roughly like this:
Lifestyle is the foundation, never removed: moderate deficit + protein + resistance training + sleep. Any drug or surgery sits on top of it, not in place of it.Drug thresholds (most FDA 2024 labels): BMI ≥ 30, or BMI ≥ 27 plus at least one weight-related comorbidity (hypertension / dyslipidemia / type-2 diabetes / sleep apnea). In STEP 1, semaglutide produced ~ -14.9% over 68 weeks, approaching magnitudes once reachable only by surgery. But note that about 2/3 of the loss returns a year after stopping (Wilding 2022) — chronic disease, chronic treatment, not a course you finish and are cured.Surgery thresholds (ASMBS/IFSO 2022): BMI ≥ 35 (with or without comorbidity), or BMI ≥ 30 with metabolic disease; Asian thresholds shift down by ~2.5. Sustained -25 to -30% loss, high T2D remission rate, at the cost of lifelong follow-up + micronutrient supplementation.
The key reframe: drugs and surgery are not 'proof of willpower bankruptcy' — they are an acknowledgment of what the earlier scenes established, that set-point defense is real biology that eating less and moving more often can't beat. Treat them as tools: used well, they solve a weight and visceral-fat problem, not a moral one.
Two deep paths: for glucagon-like peptide-1: A gut hormone released after eating that makes you feel full and helps lower blood sugar. mechanism, response curve, muscle loss, and discontinuation rebound, see `glp1-agonists-deep`; for how surgery does more than 'shrink the stomach' — gut-hormone remodeling and long-term nutrition management — see `bariatric-surgery-truth`.